BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24482498)

  • 1. Hanging tough: CMV-specific CD8+ T cells in CLL.
    Riches JC; Gribben JG
    Blood; 2014 Jan; 123(5):608-9. PubMed ID: 24482498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia.
    te Raa GD; Pascutti MF; García-Vallejo JJ; Reinen E; Remmerswaal EB; ten Berge IJ; van Lier RA; Eldering E; van Oers MH; Tonino SH; Kater AP
    Blood; 2014 Jan; 123(5):717-24. PubMed ID: 24246502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.
    Mackus WJ; Frakking FN; Grummels A; Gamadia LE; De Bree GJ; Hamann D; Van Lier RA; Van Oers MH
    Blood; 2003 Aug; 102(3):1057-63. PubMed ID: 12689926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire.
    Pourgheysari B; Bruton R; Parry H; Billingham L; Fegan C; Murray J; Moss P
    Blood; 2010 Oct; 116(16):2968-74. PubMed ID: 20562332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
    Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
    Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.
    Kater AP; Remmerswaal EB; Nolte MA; Eldering E; van Oers MH; van Lier RA
    Br J Haematol; 2004 Aug; 126(4):512-6. PubMed ID: 15287944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes.
    Mous R; Savage P; Remmerswaal EB; van Lier RA; Eldering E; van Oers MH
    Leukemia; 2006 Jun; 20(6):1096-102. PubMed ID: 16557240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia.
    Tonino SH; van de Berg PJ; Yong SL; ten Berge IJ; Kersten MJ; van Lier RA; van Oers MH; Kater AP
    Leuk Lymphoma; 2012 Sep; 53(9):1785-94. PubMed ID: 22397719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia patients have a preserved cytomegalovirus-specific antibody response despite progressive hypogammaglobulinemia.
    Vanura K; Rieder F; Kastner MT; Biebl J; Sandhofer M; Le T; Strassl R; Puchhammer-Stöckl E; Perkmann T; Steininger CF; Stamatopoulos K; Graninger W; Jäger U; Steininger C
    PLoS One; 2013; 8(10):e78925. PubMed ID: 24194956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
    Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
    Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
    Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers.
    Gamadia LE; Rentenaar RJ; Baars PA; Remmerswaal EB; Surachno S; Weel JF; Toebes M; Schumacher TN; ten Berge IJ; van Lier RA
    Blood; 2001 Aug; 98(3):754-61. PubMed ID: 11468176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analyses of leukemia-associated antigen-specific CD8
    Rücker-Braun E; Link CS; Schmiedgen M; Tunger A; Vizjak P; Teipel R; Wehner R; Kühn D; Fuchs YF; Oelschlägel U; Germeroth L; Schmitz M; Bornhäuser M; Schetelig J; Heidenreich F
    Exp Hematol; 2016 Nov; 44(11):1024-1033.e1. PubMed ID: 27473564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximity of Cytomegalovirus-Specific CD8
    Heath JJ; Fudge NJ; Gallant ME; Grant MD
    Front Immunol; 2018; 9():201. PubMed ID: 29527205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Milk Human Cytomegalovirus (CMV) Viral Load and the Establishment of Breast Milk CMV-pp65-Specific CD8 T Cells in Human CMV Infected Mothers.
    Moylan DC; Pati SK; Ross SA; Fowler KB; Boppana SB; Sabbaj S
    J Infect Dis; 2017 Nov; 216(9):1176-1179. PubMed ID: 28968907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
    Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
    Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets.
    Hassouneh F; Lopez-Sejas N; Campos C; Sanchez-Correa B; Tarazona R; Pera A; Solana R
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.
    Khan N; Hislop A; Gudgeon N; Cobbold M; Khanna R; Nayak L; Rickinson AB; Moss PA
    J Immunol; 2004 Dec; 173(12):7481-9. PubMed ID: 15585874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
    Nishida T; Hudecek M; Kostic A; Bleakley M; Warren EH; Maloney D; Storb R; Riddell SR
    Clin Cancer Res; 2009 Jul; 15(14):4759-68. PubMed ID: 19567591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
    Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
    Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.